No Bladder-Cancer Risk With Pioglitazone, Says Takeda No Bladder-Cancer Risk With Pioglitazone, Says Takeda

Takeda has submitted new data to regulatory authorities worldwide that it says show there is no bladder-cancer risk with its diabetes drug pioglitazone. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news